Elutia Inc. SEC filings ELUT
Elutia Inc. has 369 filings in SEC EDGAR's recent list, going back to Jun 9, 2017. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 21, 2026 (acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 14, 2026 | — |
| S-8 | Employee stock plan registration | Mar 25, 2026 | — |
| 424B5 | Prospectus supplement | May 8, 2025 | — |
| 424B5 | Prospectus supplement | Apr 11, 2025 | — |
| S-3 | Shelf registration | Mar 18, 2025 | — |
| 424B5 | Prospectus supplement | Feb 3, 2025 | — |
| 424B5 | Prospectus supplement | Jun 17, 2024 | — |
| 424B3 | Prospectus | Feb 14, 2024 | — |
| S-8 | Employee stock plan registration | Jan 25, 2024 | — |
| 424B3 | Prospectus | Dec 5, 2023 | — |
| S-3 | Shelf registration | Nov 20, 2023 | — |
| 424B5 | Prospectus supplement | Dec 2, 2022 | — |
| 424B5 | Prospectus supplement | Nov 30, 2022 | — |
| S-3 | Shelf registration | Aug 31, 2022 | — |
| 424B3 | Prospectus | Feb 4, 2022 | — |
| S-3 | Shelf registration | Jan 21, 2022 | — |
| S-8 | Employee stock plan registration | Oct 8, 2020 | — |
| 424B4 | Prospectus | Oct 8, 2020 | — |
| S-1/A | Amended registration statement | Sep 30, 2020 | — |
| S-1 | Registration statement | Sep 14, 2020 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ELUT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Silver Spring, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1708527
- Former names
- AZIYO BIOLOGICS, INC. (until Aug 14, 2023)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.